Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,460 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

39,460 Papers indexed
1,440 Papers AI scored
39,460 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39460 results
C
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Knowledge, Attitude and Practices towards Cervical Cancer and its Screening Among Women from Tribal Population of Anuppur District.
PMID 39578350 Published: 2024-11-23 Ingested: 2026-08-02 12:02 AM Journal of prevention (2022)
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
The Effect of Sun Knowledge and Self-Efficacy on Sun Protection Behavior in Skin Cancer Among Young People.
PMID 39527009 Published: 2024-11-11 Ingested: 2026-08-02 12:02 AM Journal of adolescent and young adult oncology
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Genomic profiling of circulating tumor DNA for childhood cancers.
PMID 39523434 Published: 2024-11-10 Ingested: 2026-08-02 12:02 AM Leukemia
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 70.0; recency: 90.0; abstract quality: 85.0.

C
"If you build it, they will come": the convergence of funding, research and collaboration in paediatric brain cancer clinical trials.
PMID 39508471 Published: 2024-11-07 Ingested: 2026-08-02 12:02 AM The Medical journal of Australia
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 90.0; human relevance: 100.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 0.0.

C
Factors influencing the physical activity among pediatric cancer survivors based on the parent-based expansion of the Theory of Planned Behavior.
PMID 39503907 Published: 2024-11-06 Ingested: 2026-08-02 12:02 AM Journal of cancer survivorship : research and practice
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Global Disparities of Cancer and Its Projected Burden in 2050.
PMID 39499513 Published: 2024-11-04 Ingested: 2026-08-02 12:02 AM JAMA network open
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 40.0; recency: 90.0; abstract quality: 100.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
How Well Are Surgical Quality Improvement Projects Planned? Review of 242 Surgical Improvement Efforts Across 5 American College of Surgeons Quality Programs.
PMID 39451129 Published: 2024-12-16 Ingested: 2026-08-02 12:03 AM Journal of the American College of Surgeons
AI -
Standard 60.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 60.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

Previous
Page 1830 of 3289
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic